All posts by: Michael Zand

About Michael Zand

CHMP backs Europe’s first allogeneic stem cell therapy – PMLiVE

Continue reading

2017-12-18 NEWS

PMLiVE

CHMP backs Europe’s first allogeneic stem cell therapy
PMLiVE
Belgian biotech TiGenix and partner Takeda have had their stem cell therapy for perianal fistulas in Crohn’s disease patients recommended for approval in the EU. The Committee for Medicinal Products for Human Use (CHMP) backed the allogeneic (donor

Continue reading

2017-12-18 NEWS

WHAS 11.com

Immunotherapy closing in on a cure for cancer
WHAS 11.com
It’s no secret, Kentucky leads the nation in lung cancer deaths as a tobacco-rich state with a high rate of radon and pollution. In the Bluegrass, more than 4,800 people are diagnosed with lung cancer every year and until recently, more than half would
Global Cancer Immunotherapy Market to 2026: AstraZeneca, Bayer AG, Hoffman La RocheMilTech
T-Cell Immunotherapy – Revolutionizing Cancer TreatmentsatPRnews (press release)

all 7 news articles »